Apixaban and Argatroban: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Aug 8, 2026 · Source data updated Jul 11, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Apixaban
Argatroban
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Apixaban (Eliquis) and argatroban are both blood thinners, and they work in different ways. When you take them together, their effects add up. That means your blood becomes even less likely to clot, which raises your risk of bleeding. In some cases that bleeding can be serious.
Please don't stop or change either medicine on your own. Sometimes doctors do use two blood thinners on purpose while switching from one to the other, and they watch you closely when they do. Watch for warning signs like unusual bruising, pink or red urine, black stools, nosebleeds that won't stop, or bleeding gums. If you notice heavy bleeding, get emergency care right away, and talk with your pharmacist or doctor about your plan.
Mechanism: Additive anticoagulation. Apixaban is a direct factor Xa inhibitor; argatroban is a direct thrombin (factor IIa) inhibitor. Neither is a prodrug, so combined use produces additive/synergistic bleeding risk (increased effect).
- Magnitude: PD studies with apixaban plus enoxaparin showed a 50 to 60% rise in anti-Xa activity; expect additive risk here.
- Severity/evidence: Major; probable.
- Onset: Unspecified; apixaban PD effect persists at least 24 hours after the last dose.
- Management: Avoid unnecessary overlap; if bleeding occurs, discontinue apixaban. A specific factor Xa reversal agent is available; PCC, aPCC, or rFVIIa may be considered. During PCC use, PT/INR/aPTT and anti-Xa monitoring are not reliable.
What happens
An increased risk of bleeding and can cause serious, potentially fatal bleeding
Interaction Deep Dive
Giving apixaban, a factor Xa inhibitor, together with another anticoagulant raises the likelihood of bleeding. Pharmacodynamic interaction studies with apixaban showed a 50% to 60% rise in anti-factor Xa activity when apixaban and enoxaparin were given at the same time. If active pathological bleeding develops, apixaban should be stopped. A product capable of reversing apixaban's anti-factor Xa activity is on the market. Apixaban's pharmacodynamic effect can be anticipated to remain for a minimum of 24 hours following the final dose. Patients should be counseled about the signs and symptoms of blood loss and instructed to report these right away or present to an emergency room. Options that may be considered include prothrombin complex concentrate (PCC), activated prothrombin complex concentrate, or recombinant factor VIIa. If PCCs are administered, checking apixaban's anticoagulant effect through a clotting assay (PT, INR, or aPTT) or anti-factor Xa (FXa) activity provides no benefit and is not advised. Activated oral charcoal decreases apixaban absorption, which in turn reduces apixaban exposure1.
Why it happens (mechanism)
Additive anticoagulation
How to manage this interaction
Keep taking both exactly as prescribed unless your care team tells you otherwise. Sometimes two anticoagulants overlap briefly during a planned transition, and your team manages this by watching you closely.
- Learn the signs of bleeding: unusual bruising, blood in urine or stool, black tarry stools, coughing or vomiting blood, prolonged nosebleeds or gum bleeding, severe headache, or dizziness.
- Report any bleeding right away or go to an emergency room.
- If serious bleeding happens, your team can stop apixaban and use a reversal agent or clotting-factor products. Remember apixaban's effect can last at least 24 hours after the last dose.
- Ask your pharmacist before adding any new medicine.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In investigations of pharmacodynamic drug interactions involving apixaban, an increase of 50% to 60% in anti-factor Xa activity was noted when apixaban and enoxaparin were given together 1.
Common questions
Can I take Apixaban and Argatroban together?
Combining apixaban and argatroban adds two blood thinners together and meaningfully raises bleeding risk. Keep taking both as prescribed, watch closely for any bleeding, and get emergency care for serious bleeding. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Apixaban and Argatroban interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Apixaban and Argatroban interaction managed?
Keep taking both exactly as prescribed unless your care team tells you otherwise. Sometimes two anticoagulants overlap briefly during a planned transition, and your team manages this by watching you closely. Learn the signs of bleeding: unusual bruising, blood in urine or stool, black tarry stools, coughing or vomiting blood, prolonged nosebleeds or gum bleeding, severe headache, or dizziness. Rep… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "probable". Good supporting evidence, though not definitively proven.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Apixaban or Argatroban need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: ELIQUIS(R) oral film coated tablets, apixaban oral film coated tablets. Bristol-Myers Squibb Company (per Dailymed), Princeton, NJ, 2024. DailyMed
Keep reading about Apixaban
Keep reading about Argatroban
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist